Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biopharmaceutical Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Interferon
  • 1.4.4 Erythropoietin
  • 1.4.5 Insulin
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Biopharmaceutical Market Share by Application (2014-2025)
  • 1.5.2 Tumor
  • 1.5.3 Diabetes
  • 1.5.4 Cardiovascular
  • 1.5.5 Hemophilia
  • 1.5.6 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Biopharmaceutical Market Size
• 2.2 Biopharmaceutical Growth Trends by Regions
  • 2.2.1 Biopharmaceutical Market Size by Regions (2014-2025)
  • 2.2.2 Biopharmaceutical Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Biopharmaceutical Market Size by Manufacturers
  • 3.1.1 Global Biopharmaceutical Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Biopharmaceutical Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
• 3.2 Biopharmaceutical Key Players Head office and Area Served
• 3.3 Key Players Biopharmaceutical Product/Solution/Service
• 3.4 Date of Enter into Biopharmaceutical Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Biopharmaceutical Market Size by Type (2014-2019)
• 4.2 Global Biopharmaceutical Market Size by Application (2014-2019)

5 United States

• 5.1 United States Biopharmaceutical Market Size (2014-2019)
• 5.2 Biopharmaceutical Key Players in United States
• 5.3 United States Biopharmaceutical Market Size by Type
• 5.4 United States Biopharmaceutical Market Size by Application

6 Europe

• 6.1 Europe Biopharmaceutical Market Size (2014-2019)
• 6.2 Biopharmaceutical Key Players in Europe
• 6.3 Europe Biopharmaceutical Market Size by Type
• 6.4 Europe Biopharmaceutical Market Size by Application

7 China

• 7.1 China Biopharmaceutical Market Size (2014-2019)
• 7.2 Biopharmaceutical Key Players in China
• 7.3 China Biopharmaceutical Market Size by Type
• 7.4 China Biopharmaceutical Market Size by Application

8 Japan

• 8.1 Japan Biopharmaceutical Market Size (2014-2019)
• 8.2 Biopharmaceutical Key Players in Japan
• 8.3 Japan Biopharmaceutical Market Size by Type
• 8.4 Japan Biopharmaceutical Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Biopharmaceutical Market Size (2014-2019)
• 9.2 Biopharmaceutical Key Players in Southeast Asia
• 9.3 Southeast Asia Biopharmaceutical Market Size by Type
• 9.4 Southeast Asia Biopharmaceutical Market Size by Application

10 India

• 10.1 India Biopharmaceutical Market Size (2014-2019)
• 10.2 Biopharmaceutical Key Players in India
• 10.3 India Biopharmaceutical Market Size by Type
• 10.4 India Biopharmaceutical Market Size by Application

11 Central & South America

• 11.1 Central & South America Biopharmaceutical Market Size (2014-2019)
• 11.2 Biopharmaceutical Key Players in Central & South America
• 11.3 Central & South America Biopharmaceutical Market Size by Type
• 11.4 Central & South America Biopharmaceutical Market Size by Application

12 International Players Profiles

• 12.1 Roche
  • 12.1.1 Roche Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Biopharmaceutical Introduction
  • 12.1.4 Roche Revenue in Biopharmaceutical Business (2014-2019)
  • 12.1.5 Roche Recent Development
• 12.2 Amgen
  • 12.2.1 Amgen Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Biopharmaceutical Introduction
  • 12.2.4 Amgen Revenue in Biopharmaceutical Business (2014-2019)
  • 12.2.5 Amgen Recent Development
• 12.3 AbbVie
  • 12.3.1 AbbVie Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Biopharmaceutical Introduction
  • 12.3.4 AbbVie Revenue in Biopharmaceutical Business (2014-2019)
  • 12.3.5 AbbVie Recent Development
• 12.4 Sanofi-Aventis
  • 12.4.1 Sanofi-Aventis Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Biopharmaceutical Introduction
  • 12.4.4 Sanofi-Aventis Revenue in Biopharmaceutical Business (2014-2019)
  • 12.4.5 Sanofi-Aventis Recent Development
• 12.5 Johnson & Johnson
  • 12.5.1 Johnson & Johnson Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Biopharmaceutical Introduction
  • 12.5.4 Johnson & Johnson Revenue in Biopharmaceutical Business (2014-2019)
  • 12.5.5 Johnson & Johnson Recent Development
• 12.6 Pfizer
  • 12.6.1 Pfizer Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Biopharmaceutical Introduction
  • 12.6.4 Pfizer Revenue in Biopharmaceutical Business (2014-2019)
  • 12.6.5 Pfizer Recent Development
• 12.7 Novo Nordisk
  • 12.7.1 Novo Nordisk Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Biopharmaceutical Introduction
  • 12.7.4 Novo Nordisk Revenue in Biopharmaceutical Business (2014-2019)
  • 12.7.5 Novo Nordisk Recent Development
• 12.8 Eli Lilly
  • 12.8.1 Eli Lilly Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Biopharmaceutical Introduction
  • 12.8.4 Eli Lilly Revenue in Biopharmaceutical Business (2014-2019)
  • 12.8.5 Eli Lilly Recent Development
• 12.9 Novartis
  • 12.9.1 Novartis Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Biopharmaceutical Introduction
  • 12.9.4 Novartis Revenue in Biopharmaceutical Business (2014-2019)
  • 12.9.5 Novartis Recent Development
• 12.10 Merck
  • 12.10.1 Merck Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Biopharmaceutical Introduction
  • 12.10.4 Merck Revenue in Biopharmaceutical Business (2014-2019)
  • 12.10.5 Merck Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
In 2018, the global Biopharmaceutical market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biopharmaceutical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical development in United States, Europe and China.

The key players covered in this study
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck

Market segment by Type, the product can be split into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other

Market segment by Application, split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biopharmaceutical status, future forecast, growth opportunity, key market and key players.
To present the Biopharmaceutical development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biopharmaceutical are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.